Cancer Moonshot Scholars
The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers and the approaches to cancer research that NCI funds. The program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce. In addition, the program seeks to increase the diversity of thought and approach to cancer research. Individuals from underrepresented groups are especially encouraged to work with their respective institutions to apply.
This program is supported by the White House's Cancer Moonshot initiative and aligns with NCI’s Equity and Inclusion Program and NIH’s UNITE Initiative. The Center to Reduce Cancer Health Disparities (CRCHD) will lead the Cancer Moonshot Scholars program, with regular input from a trans-NCI steering committee. NCI divisions that have subject matter expertise will manage the individual grant awards.
NCI intends to fund up to 15 applications each year over the next three years.
|
Funding Opportunity & CRCHD Contacts |
Application Due Dates & Purpose |
|---|---|
|
RFA-CA-22-050 (R01 Clinical Trial Optional) Dr. LeeAnn Bailey Dr. Tiffany Wallace |
Due Dates: June 6, 2023, February 6, 2024 The Cancer Moonshot Scholars program solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce.
|